
Saudi lymphoma group's clinical practice guidelines for diagnosis, management and follow-up of patients with various types of lymphoma during the Coronavirus Disease 2019 pandemic
Author(s) -
Musa Alzahrani,
Mubarak M Al-Mansour,
John Apostolidis,
Ahmed Barefah,
Reyad Dada,
Ayman Alhejazi,
Yasir Alayed,
Ibraheem Motabi,
Mansoor Radwi,
Hani Alhashmi
Publication year - 2020
Publication title -
saudi journal of medicine and medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 2
eISSN - 1658-631X
pISSN - 2321-4856
DOI - 10.4103/sjmms.sjmms_457_20
Subject(s) - medicine , pandemic , lymphoma , disease , covid-19 , coronavirus , intensive care medicine , infectious disease (medical specialty)
The Saudi Lymphoma Group had previously published recommendations on the management of the major subtypes of lymphoma. However, the effect the currently ongoing coronavirus disease 2019 (COVID-19) pandemic has on the management of patients with lymphoma has been paramount. Therefore, the Saudi Lymphoma Group has decided to provide clinical practice guidelines for the diagnosis, management and follow-up of patients with various types of lymphoma during the COVID-19 pandemic.